We used PrediXcan again to query whether low expression levels of CD36 mRNA in blood or arteries associate with type 2 diabetes complications and found strong associations between low vascular CD36 and renal, ophthalmic and neurological manifestations of type 2 diabetes (Table 2). The gene discussed is CD36; the disease is type 2 diabetes mellitus.